Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility

Elaine T. Buchert, Raymond L. Woosley, Sandra M. Swain, Stephen J. Oliver, Steven Scott Coughlin, Linda Pickle, Bruce Trock, Anna Tate Riegel

Research output: Contribution to journalArticle

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)322-327
Number of pages6
JournalPharmacogenetics
Volume3
Issue number6
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

ASJC Scopus subject areas

  • Genetics
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Buchert, E. T., Woosley, R. L., Swain, S. M., Oliver, S. J., Coughlin, S. S., Pickle, L., Trock, B., & Riegel, A. T. (1993). Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility. Pharmacogenetics, 3(6), 322-327. https://doi.org/10.1097/00008571-199312000-00006